carnitine and carboplatin

carnitine has been researched along with carboplatin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abd-Allah, AR; Al-Majed, AA; Al-Shabana, OA; Al-Yahya, AA; Fouda, SI	1
Bisonni, R; Calvani, M; D'Iddio, S; Graziano, F; Lippe, P; Mancinelli, A	1
Arafa, HM	1
Haschke, M; Herrmann, R; Krähenbühl, S; Lüde, S; Novakova, K; Todesco, L; Vitins, T	1
Chang, CC; Chou, HC; Chou, Y; Juan, SH; Sue, YM; Yang, NJ	1

Trials

1 trial(s) available for carnitine and carboplatin

Article	Year
Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1 Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine	2007

Article

Year

Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.

Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:1

Topics: Acetylcarnitine; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carnitine; Chromatography, High Pressure Liquid; Creatinine; Docetaxel; Female; Glucose; Humans; Infusions, Intravenous; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Phosphates; Taxoids; Urea; Vinblastine; Vinorelbine

2007

Other Studies

4 other study(ies) available for carnitine and carboplatin

Article	Year
L-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC). Archives of toxicology, 2005, Volume: 79, Issue:7 Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Carboplatin; Carnitine; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Glutathione; Granulocytes; Macrophages; Male; Malondialdehyde; Rats; Rats, Wistar	2005
Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids. Toxicology, 2008, Dec-05, Volume: 254, Issue:1-2 Topics: Adenosine Triphosphate; Animals; Antioxidants; Blood Urea Nitrogen; Carboplatin; Carnitine; Creatinine; Inflammation; Kidney; Kidney Diseases; Male; Nitric Oxide; Oxidants; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha	2008
Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carboplatin; Carnitine; Cells, Cultured; Cisplatin; Female; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Middle Aged; Organic Cation Transport Proteins; Organoplatinum Compounds; Oxaliplatin; Solute Carrier Family 22 Member 5	2010
L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3. PloS one, 2014, Volume: 9, Issue:8 Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Apoptosis; Carboplatin; Carnitine; Cyclooxygenase 2; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Inflammation; Kidney; Mice; NFATC Transcription Factors; PPAR alpha; Protective Agents; Rats; Reactive Oxygen Species; Signal Transduction	2014